The potential rescheduling of cannabinoids, particularly at the federal level, is generating considerable buzz within the market. A shift away from Schedule I status, often regarded as outdated and hindering progress, https://bookmarkspring.com/story15859734/pot-rescheduling-a-expansion-catalyst